Lovis; Kai

Patent Applications and Registrations

Patent applications and USPTO patent grants for Lovis; Kai.The latest application filed is for "orally administrable modified-release pharmaceutical dosage form".

Company Profile

4.9.14

Lovis; Kai - Dusseldorf DE
LOVIS; Kai - D sseldorf DE
Lovis; Kai - Wuppertal N/A DE
Lovis; Kai - Berlin DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Orally Administrable Modified-release Pharmaceutical Dosage Form App 20220257547 - Stroyer; Anke ; et al.	2022-08-18
Method for Producing (3S)-3-(4-chloro-3-{[(2S,3R)-2-(4-chlorophenyl)-4,4,4-trifluoro-3-methylb- utanoyl]amino}phenyl)-3-cyclo-propylpropanoic Acid and the Crystalline Form Thereof for Use as a Pharmaceutical Ingredient App 20220234996 - Fey; Peter ; et al.	2022-07-28
Orally administrable modified-release pharmaceutical dosage form Grant 11,344,519 - Stroyer , et al. May 31, 2	2022-05-31
Synthesis Of 4-amino-5-methyl-1h-pyridin-2(1h)-on (intermediate Compound For The Synthesis Of The Mr Antagonist Finerenone) From 2-chloro-5-methyl-4-nitro-pyridine-1-oxide Using The Intermediate Compound 2-chloro-5-methyl-4-pyridinamine App 20220153699 - Platzek; Johannes ; et al.	2022-05-19
Method for producing (3S)-3-(4-chloro-3-{[(2S,3R)-2-(4- chlorophenyl)-4,4,4-trifluoro-3-methylbutanoyl]amino}phenyl)-3-cyclo-prop- ylpropanoic acid and the crystalline form thereof for use as a pharmaceutical ingredient Grant 11,332,435 - Fey , et al. May 17, 2	2022-05-17
The Monohydrate Of Rogaratinib Hydrochloride And Solid States Thereof App 20220098201 - GRIES; Jorg ; et al.	2022-03-31
Method for Producing (3S)-3-(4-chloro-3-{[(2S,3R)-2-(4-chlorophenyl)-4,4,4-trifluoro-3-methylb- utanoyl]amino}phenyl)-3-cyclo-propylpropanoic Acid and the Crystalline Form Thereof for Use as a Pharmaceutical Ingredient App 20210179541 - FEY; Peter ; et al.	2021-06-17
Method For The Preparation Of (4s)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1-6-na- Phthyridine-3-carbox-amide By Racemate Separation By Means Of Diastereomeric Tartaric Acid Esters App 20210163474 - PLATZEK; Johannes ; et al.	2021-06-03
Orally Administrable Modified-release Pharmaceutical Dosage Form App 20210113504 - Stroyer; Anke ; et al.	2021-04-22
Orally administrable modified-release pharmaceutical dosage form Grant 10,905,667 - Stroyer , et al. February 2, 2	2021-02-02
Orally Administrable Modified-release Pharmaceutical Dosage Form App 20200030270 - Stroyer; Anke ; et al.	2020-01-30
Synthesis of copanlisib and its dihydrochloride salt Grant 10,494,372 - Peters , et al. De	2019-12-03
Synthesis Of Copanlisib And Its Dihydrochloride Salt App 20180282337 - PETERS; Jan-Georg ; et al.	2018-10-04
Synthesis of copanlisib and its dihydrochloride salt Grant 10,035,803 - Peters , et al. July 31, 2	2018-07-31
Synthesis Of Copanlisib And Its Dihydrochloride Salt App 20170327505 - PETERS; Jan-Georg ; et al.	2017-11-16
Process for preparing pan-CDK inhibitors of the formula (I), and intermediates in the preparation Grant 9,359,306 - Kruger , et al. June 7, 2	2016-06-07
Process For Preparing Pan-cdk Inhibitors Of The Formula (i), And Intermediates In The Preparation App 20130245261 - Kruger; Joachim ; et al.	2013-09-19
Large Scale Method for the deoxofluorination of ketones App 20080269512 - Lovis; Kai ; et al.	2008-10-30
Industrially applicable process for the sulfamoylation of alcohols and phenols Grant 7,067,683 - Geisler , et al. June 27, 2	2006-06-27
Multi-stage method for producing gas-filled microcapsules Grant 6,652,782 - Budde , et al. November 25, 2	2003-11-25
Industrially applicable process for the sulfamoylation of alcohols and phenols App 20030171346 - Geisler, Jens ; et al.	2003-09-11

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.